Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee hears testimony on bill to create regulated psilocybin program
Summary
Senate Bill 5201 would create a licensed, clinical psilocybin program administered by the Department of Health and the Liquor and Cannabis Board; proponents highlighted veteran mental-health needs while medical groups urged caution.
The Washington State Senate Labor & Commerce Committee on Tuesday heard testimony on Senate Bill 5201, the Clinical and Supervised Access to Psilocybin Act, which would create a regulated psilocybin program overseen by the Department of Health (DOH) and the Liquor and Cannabis Board (LCB). Committee staff said the bill would license facilitators to supervise psilocybin sessions at licensed service centers, require product testing and labeling, and exempt licensed program activities from criminal liability under the state's Controlled Substances Act.
Committee staff Marlon Yanez summarized the bill's provisions and recent state activity: "LCB must create procedures for tracking psilocybin and testing it in licensed laboratories. LCB must also require labels on…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
